The FDA Adds Intestinal Blockage Warnings to Ozempic Drug Label

The U.S. Food and Drug Administration (FDA) recently updated the label for Ozempic, a popular medication used in the treatment of type 2 diabetes, to include a potential risk of intestinal blockage, also known as ileus. This update comes in response to postmarketing reports of patients developing blocked intestines after taking Ozempic. While the FDA […]

The FDA Adds Intestinal Blockage Warnings to Ozempic Drug Label Read More ยป